Aardvark Therapeutics, Inc. - Common Stock, par value $0.00001 per share (the "Shares") (AARD)

Historical Holders from Q1 2025 to Q3 2025

Symbol
AARD on Nasdaq
Type / Class
Equity / Common Stock, par value $0.00001 per share (the "Shares")
Shares outstanding
21,303,054
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
9,465,972
Holdings value
$125,803,412
% of all portfolios
0%
Number of holders
48
Number of buys
33
Number of sells
-8
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aardvark Therapeutics, Inc. - Common Stock, par value $0.00001 per share (the "Shares") (AARD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lee Tien-Li 14% $34,103,965 2,983,724 Tien-Li Lee 31 Mar 2025
Tan Finian 9.6% $23,441,810 2,050,902 Vickers Venture Fund VI Pte. Ltd. 12 Feb 2025
CITADEL ADVISORS LLC 5.6% $13,635,659 1,192,971 Kenneth Griffin 14 Feb 2025

Institutional Holders of Aardvark Therapeutics, Inc. - Common Stock, par value $0.00001 per share (the "Shares") (AARD)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 9,465,972 $125,803,412 +$6,848,422 $13.29 48
2025 Q2 8,915,770 $120,541,916 +$8,913,830 $13.52 35
2025 Q1 8,686,452 $65,110,057 +$64,849,535 $7.51 27